| |
|
|
|
|
| Slide Lecture Programs |
| 2006 Core Curriculum |
| Contemporary Management of Myocardial Ischemia |
May 17, 2006
|
| V: |
New Therapeutic Options for Chronic Stable Angina |
Slide 51 |
|
Download PowerPoint
|
Ranolazine: Pathophysiologic effects vs older antianginals
- Late Na+ inhibitors provide additional flexibility to existing medical therapies.
- In contrast to older therapies, late Na+ inhibitors exert their effects independently of hemodynamic pathways.
- Other antianginal classes (inhibitors of Rho kinase, free fatty acid oxidation, and If current) may also be complementary to older therapies, but are investigational at present.
|
|
|
Resources
